Target intelligence / Profile preview

Mitochondrial large ribosomal subunit (39S) (39S subunit)

Target
39S subunit
Molecular classification
Ribonucleoprotein complex, Ribosome, Translation machinery
01

Overview

The mitochondrial large ribosomal subunit (39S) is a complex ribonucleoprotein assembly essential for translating the 13 proteins encoded by mitochondrial DNA, all of which are core components of the oxidative phosphorylation system (Amunts et al., 2015, Science). It consists of the 16S ribosomal RNA and approximately 50 mitochondrial ribosomal proteins (MRPLs), which facilitate peptide bond formation at the peptidyl transferase center (Greber & Ban, 2016, Annual Review of Biochemistry). Due to its endosymbiotic bacterial ancestry, the 39S subunit is structurally similar to the bacterial 50S subunit, leading to off-target inhibition by antibiotics such as linezolid and chloramphenicol (Wilson, 2014, Nature Reviews Microbiology). This inhibition can result in clinical toxicities, including lactic acidosis and bone marrow suppression, due to decreased ATP production (Garrabou et al., 2010, Antimicrobial Agents and Chemotherapy). In oncology, the 39S subunit is being investigated as a target because many cancer cells rely on mitochondrial biogenesis for survival and metastasis (Skrtic et al., 2011, Cancer Cell). Furthermore, mutations in genes encoding 39S components are associated with severe metabolic disorders, such as Leigh syndrome and combined oxidative phosphorylation deficiency (Sylvester et al., 2004, Proteomics).

Other names
39S ribosomal subunitLarge mitochondrial ribosomal subunitmt-LSUMitochondrial 39S ribosomemTLSU
02

Mechanism of action

Inhibition of mitochondrial protein synthesis by binding to the peptidyl transferase center (PTC) or the exit tunnel of the 39S subunit, preventing the assembly of oxidative phosphorylation complexes (Wilson, 2014; Leach et al., 2007).

03

Biological functions

Mitochondrial protein synthesisTranslationOxidative phosphorylationEnergy metabolism
04

Disease associations

Mitochondrial diseaseCancerInfectionAntibiotic-induced toxicityLeigh syndrome
05

Safety considerations

Mitochondrial toxicity (Garrabou et al., 2010)MyelosuppressionLactic acidosisPeripheral and optic neuropathyOtotoxicity
06

Interacting drugs

Linezolid

4 more in the full profile.

07

Biomarkers

Mitochondrial protein expression (e.g., MT-CO1)Oxygen consumption rate (OCR)Serum lactate levelsMitochondrial DNA (mtDNA) copy number

Beyond the preview

Go deeper on Mitochondrial large ribosomal subunit (39S) (39S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial large ribosomal subunit (39S) (39S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call